Likmeta, Mirlinda, et al. “CHRONIC HEPATITIS C WITH SIGNIFICANT MORBIDITY AND END-ORGAN DAMAGE DEVELOPMENT DURING PEG-INTERFERON ALPHA-2A RIBAVIRIN THERAPY”. European Scientific Journal, ESJ, vol. 11, no. 18, June 2015, https://last.eujournal.org/index.php/esj/article/view/5824.